Microbiome-Associated Drug Response Variability in Heart Failure Treatment

Andrea Rab, Annamária Magdás, Attila Frigy · 2026

Read Microbiome-Associated Drug Response Variability in Heart Failure Treatment by Andrea Rab, Annamária Magdás, Attila Frigy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13208838.txt.

Description

Andrea Rab, Annamaria Magdas, and Attila Frigy review how gut microbes change the way heart failure drugs work, in work dated 2026. Microbe mix in the gut affects drug effect and safety, yet heart failure care rarely takes it into account. Shifts in gut microbes are tied to artery disease, heart failure, and high blood pressure.

An unbalanced gut can leak and stir inflammation. Microbe made chemicals, such as TMAO and short chain fatty acids, act on the heart and vessels directly. Common heart drugs show microbe dependent handling in the body. One drug is switched off by a named gut bacterium. The review joins evidence in both directions.

Catalog record

CREATORAndrea Rab, Annamária Magdás, Attila Frigy
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13208838

Browse the full library · About the Tower of Babel